Sponsor

ImmunoGen, Inc.

Clinical research sponsor

Published trials5

Recruiting shown0

Roles2

SourceClinicalTrials.gov

Clinical trials

5 shown

A Phase 1 Study of IMGN289 in Adult Patients With EGFR-positive Solid TumorsNCT01963715 · lead sponsor · 2013-10-01

TERMINATED

A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung CancerNCT01237678 · lead sponsor · 2010-11-01

TERMINATED

Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung CancerNCT00065429 · lead sponsor · 2003-04-01

COMPLETED

BB-10901 in Treating Patients With Relapsed or Refractory Solid TumorsNCT00346385 · lead sponsor · 2002-03-01

COMPLETED

Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid TumorsNCT03102320 · collaborator · 2017-05-26

COMPLETED

Sponsor roles

lead sponsor4

collaborator1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.